The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Hepatotoxicity of antiretrovirals: Incidence, mechanisms and management
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carr, A., Samaras, K., Thorisdottir, A., Kaufmann, G. R., Chisholm, D. J., & Cooper, D. A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08468-2 · Cited by 1,495
Bica, I., McGovern, B., Dhar, R., Stone, D., McGowan, K., Scheib, R., & Snydman, D. R. (2001) · Clinical Infectious Diseases · doi:10.1086/318501 · Cited by 974
Sulkowski, M. S. (2000) · JAMA · doi:10.1001/jama.283.1.74 · Cited by 950
Flexner, C. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381808 · Cited by 852
Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway
Brinkman, K., ter Hofstede, H. J. M., Burger, D. M., Smeitink, J. A. M., & Koopmans, P. P. (1998) · AIDS · doi:10.1097/00002030-199814000-00004 · Cited by 847
van Leth, F., Phanuphak, P., Ruxrungtham, K., Baraldi, E., Miller, S., Gazzard, B., Cahn, P., Lalloo, U., van der Westhuizen, I., Malan, D., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15997-7 · Cited by 684
Sulkowski, M. S., Thomas, D. L., Mehta, S. H., Chaisson, R. E., & Moore, R. D. (2002) · Hepatology · doi:10.1053/jhep.2002.30319 · Cited by 523
Soriano, V., Sulkowski, M., Bergin, C., Hatzakis, A., Cacoub, P., Katlama, C., Cargnel, A., Mauss, S., Dieterich, D., Moreno, S., et al. (2002) · AIDS · doi:10.1097/00002030-200204120-00001 · Cited by 444
Birkus, G., Hitchcock, M. J. M., & Cihlar, T. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.716-723.2002 · Cited by 441
The use of single-nucleotide polymorphism maps in pharmacogenomics
McCarthy, J. J., & Hilfiker, R. (2000) · Nature Biotechnology · doi:10.1038/75360 · Cited by 434
den Brinker, M., Wit, F. W. N. M., Wertheim-van Dillen, P. M. E., Jurriaans, S., Weel, J., van Leeuwen, R., Pakker, N. G., Reiss, P., Danner, S. A., Jan Weverling, G., et al. (2000) · AIDS · doi:10.1097/00002030-200012220-00011 · Cited by 390
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy
Martínez, E., Blanco, J. L., Arnaiz, J. A., Pérez-Cuevas, J. B., Mocroft, A., Cruceta, A., Marcos, M. A., Milinkovic, A., García-Viejo, M. A., Mallolas, J., et al. (2001) · AIDS · doi:10.1097/00002030-200107060-00007 · Cited by 349
Idiosyncratic drug reactions: the reactive metabolite syndromes
Knowles, S. R., Uetrecht, J., & Shear, N. H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03137-8 · Cited by 331
Martin, A. M., Nolan, D., James, I., Cameron, P., Keller, J., Moore, C., Phillips, E., Christiansen, F. T., & Mallal, S. (2005) · AIDS · doi:10.1097/00002030-200501030-00014 · Cited by 317
Wit, F. W. N. M., Weverling, G. J., Weel, J., Jurriaans, S., & Lange, J. M. A. (2002) · The Journal of Infectious Diseases · doi:10.1086/341084 · Cited by 315
Drug–Induced Liver Injury: Mechanisms and Test Systems
Bissell, M. D., Gores, G. J., Laskin, D. L., & Hoofnagle, J. H. (2001) · Hepatology · doi:10.1053/jhep.2001.23505 · Cited by 267
Mechanism of indinavir-induced hyperbilirubinemia
Zucker, S. D., Qin, X., Rouster, S. D., Yu, F., Green, R. M., Keshavan, P., Feinberg, J., & Sherman, K. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231140698 · Cited by 262
Risk Factors for Severe Hepatic Injury After Introduction of Highly Active Antiretroviral Therapy
Núñez, M., Lana, R., Mendoza, J. L., Martín-Carbonero, L., & Soriano, V. (2001) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200108150-00002 · Cited by 251
Self-citationJohn, M., Flexman, J., & French, M. A. H. (1998) · AIDS · doi:10.1097/00002030-199817000-00010 · Cited by 251
Johnson, M., Grinsztejn, B., Rodriguez, C., Coco, J., DeJesus, E., Lazzarin, A., Lichtenstein, K., Rightmire, A., Sankoh, S., & Wilber, R. (2005) · AIDS · doi:10.1097/01.aids.0000166091.39317.99 · Cited by 248
Severe Hepatotoxicity Associated with Nevirapine Use in HIV‐Infected Subjects
Sanne, I., Mommeja‐Marin, H., Hinkle, J., Bartlett, J. A., Lederman, M. M., Maartens, G., Wakeford, C., Shaw, A., Quinn, J., Gish, R. G., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428093 · Cited by 242
Trends in Diseases Reported on U.S. Death Certificates That Mentioned HIV Infection, 1987–1999
Selik, R. M., Byers, R. H., & Dworkin, M. S. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200204010-00009 · Cited by 239
Stern, J. O., Robinson, P. A., Love, J., Lanes, S., Imperiale, M. S., & Mayers, D. L. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200309011-00005 · Cited by 237
Walker, U. A., Setzer, B., & Venhoff, N. (2002) · AIDS · doi:10.1097/00002030-200211080-00009 · Cited by 213
Sulkowski, M. S. (2004) · Clinical Infectious Diseases · doi:10.1086/381444 · Cited by 192
Hepatotoxicity after introduction of highly active antiretroviral therapy
Rodríguez-Rosado, R., García-Samaniego, J., & Soriano, V (1998) · AIDS · doi:10.1097/00002030-199810000-00025 · Cited by 190
Vento, S., Garofano, T., Renzini, C., Casali, F., Ferraro, T., & Concia, E. (1998) · PubMed · Cited by 168
Macías, J., Castellano, V., Merchante, N., Palacios, R. B., Mira, J. A., Sáez, C., García-García, J. A., Lozano, F., Gómez-Mateos, J. M., & Pineda, J. A. (2004) · AIDS · doi:10.1097/00002030-200403260-00007 · Cited by 167
Sulkowski, M. S., Mehta, S. H., Chaisson, R. E., Thomas, D. L., & Moore, R. D. (2004) · AIDS · doi:10.1097/00002030-200411190-00008 · Cited by 162
Aceti, A., Pasquazzi, C., Zechini, B., & Bac, C. D. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200201010-00005 · Cited by 160
Chung, R. T., Evans, S. R., Yang, Y., Theodore, D., Valdez, H., Clark, R., Shikuma, C., Nevin, T., & Sherman, K. E. (2002) · AIDS · doi:10.1097/00002030-200209270-00008 · Cited by 160
Hepatomegaly with severe steatosis in HIV-seropositive patients
Freiman, J. P., Helfert, K. E., Hamrell, M. R., & Stein, D. S. (1993) · AIDS · doi:10.1097/00002030-199303000-00012 · Cited by 151
Savès, M., Vandentorren, S., Daucourt, V., Marimoutou, C., Dupon, M., Couzigou, P., Bernard, N., Mercié, P., & Dabis, F. (1999) · AIDS · doi:10.1097/00002030-199912030-00002 · Cited by 150
Abacavir Hypersensitivity Reaction
Hewitt, R. G. (2002) · Clinical Infectious Diseases · doi:10.1086/339751 · Cited by 149
Aranzabal, L., Casado, J. L., Moya, J. L., Quereda, C., Diz, S. D. L., Moreno, A., Moreno, L., Antela, A., Pérez-Elías, M. J., Dronda, F., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/427216 · Cited by 148
Fulminant hepatitis with severe lactate acidosis in HIV‐infected patients on didanosine therapy
Bissuel, F., Bruneel, F., Habersetzer, F., CHASSARD, D., Cotte, L., Chevallier, M., Bernuau, J., Lucet, J. C., & TREPO, C. G. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01088.x · Cited by 135
Manegold, C., Hannoun, C., Wywiol, A., Dietrich, M., Polywka, S., Chiwakata, C. B., & Günther, S. (2001) · Clinical Infectious Diseases · doi:10.1086/317535 · Cited by 127
Coghlan, M. E., Sommadossi, J., Jhala, N. C., Many, W. J., Saag, M. S., & Johnson, V. A. (2001) · Clinical Infectious Diseases · doi:10.1086/323783 · Cited by 125
Incidence of Liver Injury After Beginning Antiretroviral Therapy with Efavirenz or Nevirapine
Martín‐Carbonero, L., Marina, N., Juan, G.-L., & Soriano, V. (2003) · HIV Clinical Trials · doi:10.1310/n4vt-3e9u-4bkn-crpw · Cited by 124
Savès, M., Raffi, F., Clevenbergh, P. A., Marchou, B., Waldner-Combernoux, A., Morlat, P., Moing, V. L., Rivière, C., Chêne, G., Leport, C., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3451-3455.2000 · Cited by 118
Hepatotoxicity of antiretroviral therapy.
Kontorinis, N., & Dieterich, D. T. (2003) · PubMed · Cited by 112
Monforte, A. D., Bugarini, R., Pezzotti, P., Luca, A. D., Antinori, A., Mussini, C., Vigevani, G. M., Tirelli, U., Bruno, R., Gritti, F., et al. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200110010-00002 · Cited by 107
Gisolf, E. H., Dreezen, C., Danner, S. A., Weel, J. F. L., Weverling, G. J., & for the Prometheus Study Group (2000) · Clinical Infectious Diseases · doi:10.1086/317449 · Cited by 105
Acute liver failure associated with antiretroviral treatment for HIV: a report of six cases
Clark, S. J., Creighton, S., Portmann, B., Taylor, C., Wendon, J. A., & Cramp, M. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00291-4 · Cited by 90
Hepatotoxicity Associated with Antiretroviral Therapy Containing HIV-1 Protease Inhibitors
Sulkowski, M. (2003) · Seminars in Liver Disease · doi:10.1055/s-2003-39949 · Cited by 87
Risk Factors for Hepatotoxicity in Patients Treated With Highly Active Antiretroviral Therapy
Bonfanti, P., Landonio, S., Ricci, E. D., Martinelli, C. V., Fortuna, P., Faggion, I., & Quirino, T. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200107010-00017 · Cited by 82
Kramer, J. R., Giordano, T. P., Souchek, J., & El‐Serag, H. B. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.017 · Cited by 77
Direct analysis of mitochondrial toxicity of antiretroviral drugs
Foli, A., Benvenuto, F., Piccinini, G., Bareggi, A., Cossarizza, A., Lisziewicz, J., & Lori, F. (2001) · AIDS · doi:10.1097/00002030-200109070-00012 · Cited by 76
Lack of Hepatotoxicity Associated With Nonnucleoside Reverse Transcriptase Inhibitors
Palmon, R., Koo, B. C. A., Shoultz, D. A., & Dieterich, D. T. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200204010-00003 · Cited by 75
Cooper, C., Parbhakar, M. A., & Angel, J. B. (2002) · Clinical Infectious Diseases · doi:10.1086/339867 · Cited by 69
Cytokine-mediated hepatic apoptosis
Leist, M., Gantner, F., Künstle, G., & Wendel, A. (1998) · Springer eBooks · doi:10.1007/bfb0000614 · Cited by 65
Stone, S. F., Lee, S., Keane, N. M., Price, P., & French, M. A. (2002) · The Journal of Infectious Diseases · doi:10.1086/344892 · Cited by 56
A near-fatal hypersensitivity reaction to abacavir: case report and literature review.
Shapiro, M. B., Ward, K., & Stern, J. J. (2001) · PubMed · Cited by 52
A Cohort Study of Nevirapine Tolerance in Clinical Practice: French Aquitaine Cohort, 1997–1999
Bonnet, F., Lawson‐Ayayi, S., Thiébaut, R., Ramanampamonjy, R. M., Lacoste, D., Bernard, N., Malvy, D. J.-M., Bonarek, M., Djossou, F., Beylot, J., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/343046 · Cited by 49
DRESS Syndrome Associated With Nevirapine Therapy
Claudio, G. A., Martin, A. F., Perrino, S. D. D., & Velasco, A. A. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.20.2501 · Cited by 46
HEPATOTOXICITY FOLLOWING NEVIRAPINE-CONTAINING REGIMENS IN HIV-1-INFECTED INDIVIDUALS
de Maat, M. M. R., Mathôt, R. A. A., Veldkamp, A. I., Huitema, A. D. R., Mulder, J. W., Meenhorst, P. L., Gorp, E. C. M. V., Carlier, H., & Beijnen, J. H. (2002) · Pharmacological Research · doi:10.1016/s1043-6618(02)00146-9 · Cited by 45
Cited by
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date review
Tostmann, A., Boeree, M. J., Aarnoutse, R. E., De Lange, W. C. M., Van Der Ven, A. J. A. M., & Dekhuijzen, R. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05207.x · Cited by 781
Drug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct
Fontana, R. J., Watkins, P. B., Bonkovsky, H. L., Chalasani, N., Davern, T., Serrano, J., & Rochon, J. (2009) · Drug Safety · doi:10.2165/00002018-200932010-00005 · Cited by 486
Soriano, V., Puoti, M., Sulkowski, M., Cargnel, A., Benhamou, Y., Peters, M., Mauss, S., Bräu, N., Hatzakis, A., Pol, S., et al. (2007) · AIDS · doi:10.1097/qad.0b013e3281084e4d · Cited by 349
Viral Hepatitis in HIV Infection
Koziel, M. J., & Peters, M. G. (2007) · New England Journal of Medicine · doi:10.1056/nejmra065142 · Cited by 322
Metadata
- Authors
- Núñez, M.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 44
- Issue
- 1 Suppl
- Pages
- S132-S139
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2015386493
- Cited by
- 313
- References
- 57
- FWCI
- 14.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.